Canadian Rx-to-OTC Approval Process Could Be Smoother, GSK Exec Says
This article was originally published in The Tan Sheet
Executive Summary
Canada's Rx-to-OTC switch process should be streamlined and made more industry-friendly, according to GlaxoSmithKline regulatory executive Jennifer Denomme